Please login to the form below

Not currently logged in

Teva UK appoints Richard Daniell managing director

Teva UK promotes Richard Daniell to managing director. He succeeds Dipankar Bhattacharjee who has in turn been promoted to a wider European role

Teva UK has promoted its commercial operations officer Richard Daniell to managing director.

He takes over from Dipankar Bhattacharjee who has in turn been promoted to a wider European role at the company that will see the UK form one of the territories under his guidance.

Daniell has spent more than 20 years working within the Teva group of companies.

Prior to becoming commercial operations manager in 2009 he was a senior director at Teva UK and before that spent two and a half years as director of generics at IVAX Pharmaceuticals UK.

He said: “I'm excited about driving the future and vision of Teva in the UK. We want to keep growing, and keep serving our customers well, and I'm confident we can do both of those things with the talented people we have in our team.

“I'm delighted to be leading such a forward-thinking organisation and I'm proud to be at the helm of one of the UK's leading pharmaceutical companies.”

2nd November 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...